TABLE 2.
Virulence factor carriagea
| Virulence factor | % prevalence |
|||
|---|---|---|---|---|
|
agr group I (n = 11) |
agr group II (n = 50) |
agr group III (n = 44) |
agr group IV (n = 55) |
|
| Toxin gene carriage | ||||
| expA | 0 | 8 | 9 | 22** |
| expB | 27 | 20 | 7* | 4* |
| sec-canine | 0* | 2* | 14 | 16 |
| speta | 100 | 100 | 100 | 100 |
| siet | 100 | 100 | 100 | 100 |
| luk-S/F | 100 | 100 | 100 | 100 |
| se-int | 100 | 100 | 100 | 100 |
| Antimicrobial resistance and gene carriage | ||||
| mecA | 45 | 18* | 34 | 42 |
| Aminoglycoside | 45 | 34 | 32 | 51 |
| Beta-lactam | 82 | 84 | 82 | 95 |
| Chloramphenicol | 0 | 4 | 9 | 4 |
| MLS | 45 | 18* | 34 | 45 |
| Tetracycline | 55 | 36* | 61 | 69 |
| Trimethoprim | 9* | 12* | 32 | 44 |
| MDR | 45 | 16* | 34 | 47 |
A single asterisk (*) signifies that the members of the indicated agr group are significantly less likely to be carried; double asterisks (**) signify that the members of the indicated agr group are significantly more likely to be carried.